Evaluation of the antimicrobial activity of carbapenem and cephem antibiotics against Pseudomonas aeruginosa isolated from hospitalized patients

Journal of Infection and Chemotherapy

Volumn 4, Issue 4, 1998, Pages 174-176

  Nishizawa, Kenji ^a   Hirano, Masaaki ^a   Kimura, Akio ^a   Mochizuki, Toru ^a   Yamamoto, Yasuhiro ^a   Yamamura, Shigeo ^b   Momose, Yasunori ^b  

^a NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Antimicrobial activity; Carbapenem; Cephem; MIC; Minimum bactericidal concentration (MBC); Pseudomonas aeruginosa

Indexed keywords

EID: 27144474868     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02490163     Document Type: Article

References (11)

1. Nakae T. Role of membrane permeability in determining antibiotic resistance in Pseudomonas aeruginosa. Microbiol Immunol 1995;39:221-229.
2. Tsuji A, Kaneko Y, Yamaguchi K, Goto S. Correlation between the in vitro and in vivo effects of fourteen betalactam compounds in mice with systemic infection. Chemotherapy (Basel) 1994;40:324-332.
3. Japan Society of Chemotherapy. Standard method for dilution antimicrobial susceptibility tests for bacteria (microdilution method) (in Japanese). Chemotherapy (Tokyo) 1990;38:103-105.
4. Jun I, Matsuhisa I, Takeshi N. Survey of the sensitivities of clinical isolates to antibacterial agents (annual report) (in Japanese). Jpn J Antibiot 1998;51(2):47-68.
5. Sakai C, Takagi T, Murata N, Tanaka N. Statistical and clinical study of Pseudomonas aeruginosa bacteremia complicating neoplastic disease (in Japanese). Jpn J Cancer Clin 1996;42:591-595.
6. Sumita Y, Fukasawa M. Meropenem resistance in Pseudomonas aeruginosa. Chemotherapy 1996;42:47-56.
7. Sumita Y, Fukasawa M, Okuda T. Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes. J Antibiot 1990;43:314-320.
8. Sunagawa M, Matsumura H, Sasaki A, Yamaga H, Sumita Y, Nouda H. Structure-activity relationship of 1β-methylcarbapenem to its antibacterial activity: effect of the C-2 side chain and the 1β-methyl group. J Antibiot 1996;49: 1175-1178.
9. Kuwahara-Arai K, Yokota T. In vitro antibacterial activity of cefozopran (in Japanese). Chemotherapy 1993;41(S-4):11-19.
10. Nadler HL, Pitkin DH, Sheikh W. The postantibiotic effect of meropenem and imipenem on selected bacteria. J Antimicrob Chemother 1989;24(S-A):S225-S231.
11. Sumita Y, Fukasawa M. The increased antipseudomonal activity of meropenem in minimal medium (in Japanese). Chemotherapy (Tokyo) 1995;43:393.